PR Newswire: CareSignal Announces At-Risk Pricing Option, Driven by Confidence in Implementation Practices and Clinical Outcomes
At-risk pricing brings innovation to patients faster while helping providers and plans confidently invest resources to create the largest clinical and financial impact in value-based care populations.
CareSignal has supported tens of thousands of individual patients with heart failure, COPD, diabetes, depression, and dozens of other conditions for a combined duration of more than 20,000 patient-years.
CareSignal announces the launch of CareSignal AI to address one of the most pressing areas in healthcare: patient disengagement.
NOTE: In 2020, Epharmix rebranded to CareSignal. References to Epharmix and Epx are outdated. St. Louis-based digital health company provides easy-to-use patient communication tools that lead to improved patient engagement and outcomes ST. LOUIS, MO & WEST DES...